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• The RER database does not include inpatient medications (potential 
underestimation of PIM exposure). 
• Although adjusted for available confounders, causality of 
hospitalizations is unknown. 
  
Did a physician-targeted intervention that reduced potentially 
inappropriate prescribing to elderly patients also reduce related 
hospitalizations?  
McRae JM1, Hegarty S2, Alcusky M1, Vegesna A1, M, Varga S1,Keith SW2, Del Canale S3, 
Lombardi M3, Maio V1 
• A potentially inappropriate medication (PIM) is a drug that may be 
inappropriate because the risks outweigh the potential benefits.1 
• PIM use in the elderly can be especially harmful due to less effective 
clearance systems, frail bodies, and polypharmacy.2,3 
• Maio and colleagues estimated that approximately 20% of elderly 
Emilia-Romagna residents were prescribed a PIM in 2006.4 
• A retrospective, longitudinal analysis of over 1.4 million elderly, Emilia-
Romagna residents (2003-2013) demonstrated that individuals 
exposed to a PIM were 16% more likely to be hospitalized than 
persons unexposed to PIM.5  
• Evidence of the clinical effectiveness of interventions aimed at 
reducing PIM prescribing in the elderly is limited and has yielded 
mixed results.6 
To determine whether a general practitioner focused intervention aimed at 
decreasing PIM prescribing in the elderly can decrease the risk of PIM-
related hospitalizations.   
PIM Exposure & Hospitalizations 
• Approximately 411 PIM-related hospitalizations were avoided in Parma 
LHA and elderly residents during post-intervention were at significantly 
lower risks of PIM-related hospitalizations than pre-intervention.  
• We believe that the observed decline in PIM-hospitalizations within 
Parma LHA was attributable to the decreased exposure to PIMs. 
• To our knowledge this is the first study to evaluate the effectiveness of 
a multi-year, PIM awareness program with respect to incident 
hospitalizations.  
• We believe that the observed decreased risk of PIM-related 
hospitalizations in Parma LHA post-intervention was due to changes in 
physician behavior. 
• We urge researchers to continue to evaluate the effectiveness of 
interventions targeted at increasing awareness of the potential harms of 
PIM in the elderly.  
Table 1. Demographics, 2008 
This study was reviewed by the Thomas Jefferson University IRB and 
determined not to constitute human subjects research.  
Intervention 
• Implemented over a 2 year time period: 2008-2009.7  
• Serving residents of the Local Health Authority (LHA) of Parma, Emilia-
Romagna region (RER), Italy, one of the 11 regional LHAs. 
• Aimed to engage 303 general practitioners (GPs) on PIM awareness in 
the elderly population. 
• The three components of the intervention included: 
1. Circulation of a developed list of PIM to “always be avoided” 
and a list of alternatives. 
2. Annual reviews of incidence of PIM use in the elderly. 
3. Educational sessions on PIM use (academic, case reviews). 
Comparators 
• We evaluated the effectiveness of the physician-directed PIM 
intervention by comparing the risk of PIM-related hospitalizations for 
residents under the care of a general practitioner (GP) in Parma LHA 
during and after intervention (post-intervention, 1/1/2008-9/30/2011) to 
residents under the care of a GP in the rest of the RER (Non-Parma). 
Study Population 
• Study time period: 01/01/2005 – 09/30/2011. 
• Elderly individuals (≥65 years old) who were residents of RER for at 
least one year were included in the cohort.  
• Individuals exited the cohort at the earliest time they met one of the 
following criteria: death, moved out of the region, or hospitalization for 
more than 30 consecutive days.  
Modeling 
• We developed a time-dependent covariate, repeated-events, Cox 
Proportional Hazard Model using fully-linked longitudinal administrative 
claims from the RER database.  
• Event of interest: PIM-related hospitalizations, defined as an 
unplanned, inpatient hospitalization occurring during PIM exposure. 
• Defined PIM: Drugs that should be “always be avoided”, according to the 
2007 Maio Criteria.8  
• To estimate PIM exposure we computed the number of days supplied for 
each medication of interest (using Defined Daily Doses) and added 30 
days to capture any residual effects of a PIM.  An individual was 
considered exposed to PIM from the date the prescription was filled until 
30 days after the prescription was expected to end based on DDD. 
• Adjustments for the outcome included: age, gender, number of non-PIM 
hospitalizations (in the previous four quarters), number of chronic 
condition drug groups (CCDGs) (in the previous four quarters).9 
Calculations 
• Demographics were summarized for Parma and Non-Parma at the start 
of the intervention (01/01/2008).  
• Unadjusted PIM exposure and PIM related-hospitalizations were 
estimated for Parma vs. Non-Parma residents.  
• We used Cox modeling to estimate adjusted hazard ratios (HRs) of 
PIM-related hospitalizations for Parma post vs. pre-intervention.  
• We calculated the number of PIM-related hospitalizations avoided in 
Parma post-intervention vs. pre-intervention (Figure 1).  
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 n(%) N % 
No. Patients 906,810 100% 816,325 (100%) 90,485 (100%) 
Exposed to PIM (yes) 76,070 8.4% 68,798  (8.4%) 7,272 (8.0%) 
Female  522,895 57.7% 470,132 (57.6%)  52,763 (58.3%) 
Age 
   65-74 years 459,946 50.7% 414,590 (50.8%) 45,356 (50.1%) 
   75- 84 years 328,065 36.2% 295,318 (36.2%) 32,747 (36.2%) 
   >84 years 118,799 13.1% 106,417 (13.0%) 12,382 (13.7%) 
Hospitalizations, 2007 
    0 757,427 83.5% 681,609 (83.5%) 75,818 (83.8%) 
   1-2 134,989 14.9% 121,658 (14.9%) 13,331 (14.7%) 
   3-4 12,207 1.3% 11,043 (1.4%) 1,164 (1.3%) 
   5+ 2,187 0.2% 2,015 (0.2%) 172 (0.2%) 
CCDGs, 2007 
   0 53,241 5.9% 47,367 (5.8%) 5,874 (6.5%) 
   1-2 378,357 41.7% 339,836 (41.6%) 38,521 (42.6%) 
   3-4 334,820 36.9% 302,291 (37.0%) 32,529 (35.9%) 
   5+ 140,392 15.5% 126,831 (15.5%) 13,561 (15.0%) 
• In 2005, residents of Parma and Non-Parma were exposed to 
approximately 8 person years (PYs) of PIM per 100 PYs follow-up time 
(Figure 2).  
• Post-intervention, we observed a decrease in exposure to PIM, 
appearing a more drastic decline in Parma than Non-Parma.  
• Post-intervention there appears to be a decline in PIM-related 
hospitalizations in Parma consistent with the decline in PIM-exposure 
(post-intervention).  
RESULTS 
• When the intervention was introduced in 2008, there were 906,810 
elderly residents in the Emilia-Romagna region and approximately 
1/10th were under the care of a Parma GP.  
• The exposure to PIM, previous hospitalizations, and comorbid status, 
gender, and age strata of residents in Parma and Non-Parma were 
similar. 
Demographics 
Data for this study was retrieved from the Regional database of the Emilia-Romagna 
Region, provided through a collaborative agreement between the Health Care Authority, 
Regione Emilia-Romagna, Italy, and Thomas Jefferson University.  
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Figure 2. Parma vs. Non-Parma Trends, 2005-2011 
Hazard Ratios 
• Compared with others in the RER during the same periods, Parma 
residents post-intervention were 7% less likely to have a PIM-related 
hospitalization than pre-intervention (Table 2). 
• We estimated that approximately 411 PIM-related hospitalizations were 
avoided due to the intervention.  
HR (95% CI)  P value 
Post- vs. Pre- Intervention 0.93  (0.89, 0.97) 0.002 
Female 0.90 (0.89, 0.91) <0.001 
Age 1.08 (1.08, 1.08) <0.001 
1+ CCDG 1.50 (1.50, 1.51) <0.001 
1+ hospitalization 1.23 (1.23, 1.24) <0.001 
Table 2. Cox Model Results 
INTRODUCTION 
